Standard Life Private Equity Trust (LON:SLPE) Trading Up 2.6% - Still a Buy?

Key Points

• Shares rose 2.6% to GBX 620 on Wednesday, with about 42,436 shares traded — a 73% drop from the average daily volume, indicating the move occurred on much lighter-than-normal trading.
• The trust has a market cap of £953.23 million and a price-to-earnings ratio of 3.33, and the stock is trading above both its 50‑day (GBX 588.67) and 200‑day (GBX 602.54) moving averages.
• Standard Life Private Equity Trust acts as a fund-of-funds and direct investor focused on mid‑market buyouts and expansion capital across sectors like healthcare, oil & gas services and aero‑engineering, targeting companies with enterprise values of EUR100m–EUR2bn.

Standard Life Private Equity Trust (LON:SLPE - ) shares were up 2.6% during trading on Wednesday . The company traded as high as GBX 620 and last traded at GBX 620. Approximately 42,436 shares traded hands during trading, a decline of 73% from the average daily volume of 157,693 shares. The stock had previously closed at GBX 604.

Standard Life Private Equity Trust Stock Up 2.6%

The firm has a market cap of £953.23 million and a price-to-earnings ratio of 3.33. The business has a 50 day moving average of GBX 588.67 and a 200 day moving average of GBX 602.54.

About Standard Life Private Equity Trust

SL Private Equity specializes in fund of funds and direct investments. It seeks to invest in mid-market buyouts and expansion capital. It focuses on investments in healthcare, oil and gas services, educational publishing, aero-engineering, and capital goods outside Europe. Within fund of fund investments it seeks to invest in private equity funds focused on mid to large sized buyouts. It seeks to invest in funds investing in companies with enterprise values ranging between EUR100 million ($111.10 million) and EUR2 billion ($2,881.60 million).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.